The Net Margin of Kaken Pharmaceutical Co Ltd (4521.T) is 14.83%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | 14.83% |
| 2024-03-31 | 11.14% |
| 2023-03-31 | 7.45% |
| 2022-03-31 | 12.56% |
| 2021-03-31 | 17.88% |
| 2020-03-31 | 21.71% |
| 2019-03-31 | 18.88% |
| 2018-03-31 | 19.35% |
| 2017-03-31 | 21.70% |
| 2016-03-31 | 19.27% |